A

Aileron Therapeutics
D

ALRN

1.87000
USD
0.12
(6.86%)
Market Closed
Volume
5,953
EPS
-2
Div Yield
-
P/E
-1
Market Cap
40,515,310
OverviewSignalsIdeasNews
Related Instruments
    A
    AL
    0.030
    (0.06%)
    48.620 USD
    A
    ALG
    -2.060
    (-1.09%)
    186.390 USD
    A
    ALKS
    -0.260
    (-0.87%)
    29.490 USD
    ALNY
    ALNY
    -3.355
    (-1.37%)
    242.150 USD
    A
    ALR
    0.000000
    (0.00%)
    0.000000 USD
    A
    ALRM
    -1.680
    (-2.67%)
    61.300 USD
    A
    ALRS
    -0.170
    (-0.85%)
    19.810 USD
    More
News

Title: Aileron Therapeutics

Sector: Healthcare
Industry: Biotechnology
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development,LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.